HomeGH • NASDAQ
add
Guardant Health Inc
Previous close
$46.17
Day range
$43.66 - $46.37
Year range
$20.14 - $53.42
Market cap
5.56B USD
Avg Volume
2.27M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 232.09M | 30.95% |
Operating expense | 257.07M | 25.32% |
Net income | -99.90M | 2.66% |
Net profit margin | -43.04 | 25.68% |
Earnings per share | -0.44 | 8.33% |
EBITDA | -96.14M | -7.19% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 522.81M | -46.99% |
Total assets | 1.33B | -17.23% |
Total liabilities | 1.64B | 1.65% |
Total equity | -305.48M | — |
Shares outstanding | 124.71M | — |
Price to book | -18.84 | — |
Return on assets | -19.84% | — |
Return on capital | -25.47% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -99.90M | 2.66% |
Cash from operations | -60.28M | 35.87% |
Cash from investing | -10.65M | -109.75% |
Cash from financing | 1.62M | -72.47% |
Net change in cash | -68.37M | 27.28% |
Free cash flow | -136.23M | -87.22% |
About
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
Founded
2012
Headquarters
Website
Employees
2,010